B-Cell Lymphoma in a Patient with Complete Interferon Gamma Receptor 1 Deficiency

Hannelore Bax, AF Freeman, VL Anderson, P Vesterhus, D Laerum, S Pittaluga, WH Wilson, SM Holland

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)

Abstract

Immunosuppression-associated lymphoproliferative disorders can be related to primary as well as acquired immune disorders. Interferon gamma receptor (IFN-gamma R) deficiency is a rare primary immune disorder, characterized by increased susceptibility to mycobacterial infections. Here we report the first case of an Epstein Barr Virus (EBV) related B-cell lymphoma in a patient with complete IFN-gamma R1 deficiency. The patient was a 20-year-old man with homozygous 22Cdel in IFNGR1 resulting in complete absence of IFN-gamma R1 surface expression and complete lack of responsiveness to IFN-gamma in vitro. He had disseminated refractory Mycobacterium avium complex and Mycobacterium abscessus infections. At age 18 he presented with new spiking fever and weight loss that was due to an EBV-positive B-cell non-Hodgkin lymphoma. Two years later he died of progressive lymphoma. IFN-gamma plays an important role in tumor protection and rejection. Patients with IFN-gamma R deficiencies and other immune deficits predisposing to mycobacterial disease seem to have an increased risk of malignancies, especially those related to viral infections. As more of these patients survive their early infections, cancer awareness and tumor surveillance may need to become a more routine part of management.
Original languageUndefined/Unknown
Pages (from-to)1062-1066
Number of pages5
JournalJournal of Clinical Immunology
Volume33
Issue number6
DOIs
Publication statusPublished - 2013

Research programs

  • EMC MM-04-28-04

Cite this